Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-3/A Offering Registration Statement
  6. UPLOAD Other SEC-generated Letter
  7. S-3 Offering Registration Statement
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-3 Offering Registration Statement
  13. UPLOAD Other SEC-generated Letter
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. 424B5 Offering Prospectus
  19. 424B5 Offering Prospectus
  20. 424B5 Offering Prospectus

Page 1 of 3 · 42 filings